Everolimus is effective in maintenance liver transplant patients: A multicenter, randomized trial

被引：0
|
作者：
de Simone, Paolo [1 ]
Nevens, Frederik [2 ]
Metselaar, Herald [3 ]
Sterneck, Martina [4 ]
Dumortier, Jerome [5 ]
Rostaing, Lionel [6 ]
Giostra, Emiliano [7 ]
Varo, Evaristo [8 ]
机构：
[1] Univ Pisana, Azienda Osped, Pisa, Italy
[2] UZ Gasthuisberg, Louvain, Belgium
[3] Erasmus MC, Rotterdam, Netherlands
[4] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[5] Hop Edouard Herriot, Lyon, France
[6] CHU Rangueil, Lyon, France
[7] Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland
[8] Univ Santiago de Compostela, Hosp Clin, Santiago De Compostela, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients
    Budde, K
    Fritsche, L
    Waiser, J
    Glander, P
    Slowinski, T
    Neumayer, HH
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (04) : 169 - 174
  • [22] CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS
    Vallin, M.
    Guillaud, O.
    Morard, I.
    Gagnieu, M-C
    Mentha, G.
    Adham, M.
    Morelon, E.
    Giostra, E.
    Boillot, O.
    Dumortier, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S186 - S186
  • [23] EFFECTS OF EVEROLIMUS ON TRIGLYCERIDES IN LIVER TRANSPLANT PATIENTS
    Alimirah, Maryam
    Sadiq, Omar
    Kaur, Randeep
    Kumssa, Fitsum
    Patel, Anita
    Jafri, Syed-Mohammed
    GASTROENTEROLOGY, 2018, 154 (06) : S1146 - S1146
  • [24] Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Dong, G.
    Lopez, P.
    TRANSPLANTATION, 2012, 94 (10) : 9 - 9
  • [25] LATE CONVERSION TO EVEROLIMUS IN MAINTENANCE LIVER TRANSPLANT PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    GASTROENTEROLOGY, 2018, 154 (06) : S1147 - S1147
  • [26] EVEROLIMUS WITH REDUCED TACROLIMUS PREFERENTIALLY BENEFITS PATIENTS WITH IMPAIRED RENAL FUNCTION IN MAINTENANCE LIVER TRANSPLANT
    Lin, Yih Jyh
    Chou, Tsung-Ching
    Chen, Ren Long
    TRANSPLANT INTERNATIONAL, 2017, 30 : 252 - 253
  • [27] The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients
    Keiding, S
    Hockerstedt, K
    Bjoro, K
    Bondesen, S
    Hjortrup, A
    Isoniemi, H
    Erichsen, C
    Soderdahl, G
    Ericzon, BG
    TRANSPLANTATION, 1997, 63 (11) : 1591 - 1594
  • [28] Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial
    Cillo, Umberto
    Saracino, Laura
    Vitale, Alessandro
    Bertacco, Alessandra
    Salizzoni, Mauro
    Lupo, Francesco
    Colledan, Michele
    Corno, Vittorio
    Rossi, Giorgio
    Reggiani, Paolo
    Baccarani, Umberto
    Bresadola, Vittorio
    De Carlis, Luciano
    Mangoni, Iacopo
    Morales, Raphael Ramirez
    Agnes, Salvatore
    Nure, Erida
    LIVER TRANSPLANTATION, 2019, 25 (02) : 242 - 251
  • [29] Everolimus versus azathioprine in maintenance lung transplant recipients: An international, randomized, double-blind clinical trial
    Snell, GI
    Valentine, VG
    Vitulo, R
    Glanville, AR
    McGiffin, DC
    Loyd, JE
    Roman, A
    Aris, R
    Sole, A
    Hmissi, A
    Pirron, U
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) : 169 - 177
  • [30] Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Boillot, Olivier
    Giostra, Emiliano
    Dumortier, Jerome
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 660 - 669
12345